Blog

High-Throughput PCR in CRISPR Screening and Genome Editing Verification

High-Throughput PCR in CRISPR Screening and Genome Editing Verification

Genome editing technologies have transformed both agricultural and life sciences research, enabling scientists to make precise, targeted changes to DNA with unprecedented speed and accuracy. Among these technologies, CRISPR/Cas systems have become the dominant tool for editing genes, regulatory regions, untranslated regions, and intergenic sequences. As genome editing adoption accelerates, so too does the need for high-throughput PCR methods that can rapidly and reliably verify edits across large sample populations.

While high-throughput sequencing (HTS) remains a gold standard for detailed characterisation, it is not always the most efficient or cost-effective solution for early-stage screening. High-throughput PCR, particularly when combined with PACE® allele-specific genotyping, offers a powerful alternative for CRISPR screening and genome editing verification.

The Challenge of Screening CRISPR Gene Edits at Scale

CRISPR-mediated genome editing can generate a wide spectrum of genetic outcomes, including:

  • Small or large insertions and deletions (indels)
  • Single base-pair substitutions
  • Frameshift mutations
  • Gene knockouts

These edits are typically introduced through either Non-Homologous End Joining (NHEJ), which produces random mutations at the cut site, or Homology-Directed Repair (HDR), which enables precise, template-driven edits. In any genome editing experiment, researchers must efficiently distinguish successfully edited samples from wild-type material—often across hundreds or thousands of individuals.

Traditionally, sequencing has been used for this task. However, sequencing-based screening presents several limitations when applied at scale:

  • High costs, particularly for large populations
  • Stringent DNA purity requirements, increasing sample preparation time
  • Data overload, requiring bioinformatics expertise to interpret large datasets

These challenges have driven demand for scalable, affordable, and rapid high-throughput PCR solutions that can act as a primary screening step before sequencing.

High-Throughput PCR with PACE® Allele-Specific Genotyping

PACE® (PCR Allele Competitive Extension) genotyping is a robust, high-throughput PCR technology designed to rapidly detect specific genetic variants with high accuracy. It is ideally suited for CRISPR screening and genome editing verification in both agricultural and life sciences research.

PACE genotyping uses competitive allele-specific primers and a universal fluorescent reporting system to distinguish edited alleles from wild-type sequences in a single PCR reaction. This approach enables fast, machine-readable genotype calls without any post-PCR processing.

Key Benefits of PACE-Based High-Throughput PCR

PACE genotyping addresses the limitations of sequencing by offering:

  • Broad applicability: Compatible with plants, animals, tissue cultures, protoplasts, seeds, and single cells
  • High efficiency: Detects SNPs, knockouts, and both small and large indels using simple, unlabelled primers
  • Cost-effectiveness: Requires minimal DNA input and works with crude lysates and high-throughput extraction methods
  • High accuracy: Allele-specific primers precisely discriminate between edited and wild-type sequences
  • Scalability: Ideal for breeding programmes, large screening studies, and industrial-scale genotyping
  • Ease of use: Combines amplification and fluorescence detection in one step

This makes PACE an ideal high-throughput PCR solution for researchers seeking to streamline CRISPR screening workflows.

CRISPR Gene Edit Detection Assays from 3CR Bioscience

3CR Bioscience’s CRISPR Gene Edit Detection Assays combine the power of PACE genotyping with custom assay design to deliver fast, affordable, and reliable high-throughput PCR screening of genome edits.

Our assays are designed using DNA sequences you provide, including the target site, spacer, and PAM. They can detect edits introduced via directed CRISPR editing or NHEJ, even when the exact mutation is unknown.

How the PACE CRISPR Detection Assay Works

  1. Assay design: Submit your target DNA sequence following our guidelines
  2. Assay delivery: Receive ready-to-use, pre-validated PACE CRISPR detection assays
  3. Reaction setup: Assemble reactions using PACE assays and PACE Genotyping Master Mix
  4. Run and analyse: Perform PCR and rapidly identify edited samples via fluorescence
  5. Follow-up: Confirm selected samples by sequencing if required

Each order includes 400 µL of ready-to-use 72× PACE assay, sufficient for at least 2,800 reactions at a 10 µL volume. All assays are proprietary and confidential.

PACE Genotyping Master Mix

Spotlight: High-Throughput PCR in Plant Breeding

CRISPR/Cas systems are now central to modern plant breeding, enabling the development of crops with improved yield, resilience, and quality traits. High-throughput PCR using PACE genotyping supports plant breeding at every stage:

  • Early detection of edits to optimise transformation protocols
  • Bulk screening of seed or grain populations for trait purity
  • Generation of robust data for regulatory submissions
  • Monitoring genome edits in commercial products

PACE can detect all classes of edits, from single nucleotide changes (SDN1) to large rearrangements (SDN3), and can also be used to monitor potential off-target modifications.

Accelerating Genome Editing with High-Throughput PCR

High-throughput PCR has become an essential component of modern genome editing workflows. By offering a rapid, scalable, and cost-effective alternative to sequencing for primary screening, PACE® allele-specific genotyping empowers researchers to move faster and more efficiently.

Whether you are improving crop traits, developing edited cell lines, or optimising CRISPR protocols, 3CR Bioscience’s CRISPR Gene Edit Detection Assays provide the accuracy, speed, and scalability needed to transform your genome editing workflow.

MORE POSTS

Automated Pipetting vs. Manual Pipetting: Which Is Right for Your Lab?
Discover when manual pipetting is enough—and why automated pipetting with 3CR’s GeneArrayer and PACE® genotyping delivers superior speed, accuracy, and scalability.
High-Throughput PCR in CRISPR Screening and Genome Editing Verification
Discover how high-throughput PCR using PACE® genotyping accelerates CRISPR screening and genome editing verification across large sample populations.
Understanding the genetics of important traits in hemp to help breed improved cultivars
Learn how Cornell University uses PACE® SNP genotyping to accelerate hemp breeding—enabling early trait selection, sex determination, and cost-effective genetic screening.

Our product portfolio for your PCR genotyping workflow

Our portfolio of products and services include PACE® genotyping chemistry, instruments, and lab services to streamline every step of your workflow. Designed for life sciences, biotech, and agricultural research, our high-performance reagents, reliable instruments, and expert lab support help you achieve accurate, consistent results while reducing time and costs – making science affordable.

[fibosearch]
This field is for validation purposes and should be left unchanged.
Name(Required)

Contact us

Stay up to date with all things 3CR. 

Sign up now to receive insights, updates 
and industry case studies. 

This field is for validation purposes and should be left unchanged.
Name(Required)

MEET OUR TEAM

Steve AsquithManaging Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John HolmeTechnical Director

John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base.

During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASP™, KlearKall, KlearGene, KlearAmp and KlearTaq™, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Dr. Nisha JainOperations Director

Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP.

Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Nazma SaffinGeneral Manager
For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.
Greig PollandAutomation and Support Manager

Greig is a hands-on automation specialist and team leader with a strong background in laboratory and industrial automation. He has spent over 25 years developing, installing, and supporting automated systems that transformed laboratory workflows. During this time, Greig worked closely with scientists and engineers to tailor automation solutions for genotyping and molecular biology, an experience that sparked his lasting passion for combining technology with practical science.

Since then, Greig has built on that foundation through leadership roles where he leads automation and support operations. He’s known for being approachable, commercially minded, and deeply committed to helping teams and customers get the best from their technology.

Whether managing a complex automation rollout or helping a customer troubleshoot in real time, Greig brings a thoughtful, collaborative approach that keeps people ,not just machines, at the centre of what he does.